Qure.ai nets $65M for foundational AI
Qure.ai has raised $65 million in a Series D funding round led by Lightspeed and 360 ONE Asset.
The company said it will use its fresh funds to invest more in foundational AI models, as well as acquire complementary startups in medical technology. It will also be used to accelerate its expansion in the United States and other markets.
Early this year, the...
Indian medical imaging AI company InMed AI has released a new AI-powered tool for screening traumatic brain injuries (TBI).
The Neuroshield CT TBI is a decision support tool for detecting and quantifying intracranial haemorrhage, fracture, and midline shift. Utilising AI, it automatically processes brain CT images and alerts clinicians of critical findings.
Commenting on the technology, Dr...
New player in digital diabetes management
Diabetes app Smit.fit from India and Qatar-based digital therapeutics (DTx) company Droobi Health have announced their merger.
The combined entity called DroobiSmit, headquartered in Singapore, aims to be a leading diabetes solution provider in the Middle East and South Asia regions. It will offer personalised solutions for people with pre-diabetes,...
Qure.ai is the latest technology partner to join Medtronic's initiative in advancing stroke care management in India.
According to a press statement, their partnership aims to provide AI solutions to comprehensive stroke centres and primary stroke centres. They also seek to establish a hub-and-spoke network that will assist in faster identification, decision-making, and triaging of stroke...
Indian biotech company Mylab Discovery Solutions is integrating Qure.ai's AI technology into its upcoming x-ray device for screening tuberculosis.
According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai's deep-learning software qXR to analyse chest x-ray images and identify TB within a minute...
Taiwan clears VUNO's AI fundus analysis tool
South Korean firm VUNO has gained the approval of Taiwan's Food and Drug Administration to market its AI fundus analysis software.
VUNO Med-Fundus AI analyses images of the fundus to quickly detect locations of lesions indicative of retinal diseases, including diabetic retinopathy, macular disease and glaucoma.
This latest certification follows Taiwan...
Pediatric behavioral health company Brightline raised a whopping $105 million, pushing its valuation to $705 million, according to reporting by Bloomberg.
The round was led by KKR & Co., with participation from existing investors, including GV, Optum Ventures, Oak HC/FT Partners Threshold Ventures and Blue Cross Blue Shield of Massachusetts. CEO Naomi Allen told Bloomberg it would use the...
Qure.ai scores £3.2M for AI-aided cancer detection
Artificial intelligence (AI) provider Qure.ai has secured £3.2 million from SBRI Healthcare, in partnership with the NHS cancer programme and NHS Accelerated Access Collaborative.
The funding will be used to demonstrate real-world evidence of AI-aided lung cancer diagnosis, using the firm’s qXR chest X-ray interpretation technology.
Prof David...
Qure.ai scored FDA 510(k) clearance for its artificial intelligence algorithm that assists providers in placing breathing tubes.
The clearance, which officially came down in late December, is the company's third 510(k). The two previous FDA green lights were regarding its brain CT scan product.
Using chest x-rays, the qXR-BT algorithm can analyze the position of the breathing tube. It automates...
Artificial intelligence startup Fractal announced on Wednesday that it had raised $360 million from private equity firm TPG.
Srikanth Velamakanni, cofounder and group chief executive at Fractal, told TechCrunch the investment will earn the company unicorn status, reaching a valuation “at well north of $1 billion.”
Fractal, which is the parent company of healthcare AI company Qure.ai, will receive...
